BrainsWay Announces Private Insurance Coverage from Premera Blue Cross for the Treatment of OCD Utilizing Deep TMS™
Premera provides commercial health coverage to more than 2.6 million people in the
“Mental health and behavioral health are of paramount importance in our society, and better access to providers and appropriate levels of care is absolutely critical. The expanded coverage by Premera, for both OCD and depression, will make a tremendous difference in the lives of patients,” said
In further support of these expanded access trends, final and draft Local Coverage Determinations, respectively, were recently issued by CGS and NGS, two Medicare Administrative Contractors (MACs), reducing the number of previous medication failures required to qualify for TMS treatment for MDD from four to two. These MACs collectively represent 14.5 million covered lives, and once implemented, the changes will result in all 60+ million Medicare beneficiaries in the country qualifying for Deep TMS depression coverage after either one or two failed medication trials. Private payers including Anthem,
Furthermore, NGS is now expanding its TMS coverage criteria to include psychiatric nurse practitioners, making it the first MAC to join the commercial payers who have already taken this step, including Magellan, Centene, HCSC, Premera,
BrainsWay’s patented H-Coil technology was first FDA-cleared for treating depression in 2013 and OCD in 2018, and is designed to penetrate deeper and broader structures of the brain than traditional TMS coils.
About
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, historical results or conclusions from scientific research and clinical studies do not guarantee that future results would suggest similar conclusions or that historical results referred to herein would be interpreted similarly in light of additional research or otherwise. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies on the Company’s anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Company’s intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, which could cause the actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements.
Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s filings with the
Contacts:
Scott.Areglado@BrainsWay.com
Investors:
646-597-6989
Bob@LifeSciAdvisors.com
Media Contact:
Meghan.Laska@BrainsWay.com
Source:


SageSure Announces Innovative Private Flood Insurance in Texas
Leia Inc. Announces $125M Debt Financing from Aon
Advisor News
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
More Annuity NewsHealth/Employee Benefits News
- Vermont public schools expect the lowest health insurance increase in years. For districts, it’s only a small relief.
- Vt. public schools expect the lowest health insurance increase in years
- Samantha Wildow: Mercy Health warns thousands of Medical Mutual of Ohio patients may go out-of-network in 2027
- Reports Outline Managed Care Study Results from Harvard University (Inpatient-Only List Removals Shifted Procedures To The Outpatient Setting And Reduced Medicare Spending): Managed Care
- Health and Humor: Picking a Medicare insurance plan is daunting
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- U-Haul Holding Company to Participate in Deutsche Bank Conference
- NAIC task force to address LTC riders
- Protective names Kurt Meyers Chief Legal Officer and Fernando Levy Chief Digital & AI Officer
- Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
More Life Insurance News